Corvus Pharmaceuticals Inc (CRVS)
1.95
+0.03
(+1.56%)
USD |
NASDAQ |
May 06, 16:00
2.09
+0.14
(+7.18%)
After-Hours: 17:57
Corvus Pharmaceuticals Cash and Short Term Investments (Quarterly): 27.15M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.15M |
| September 30, 2023 | 32.17M |
| June 30, 2023 | 37.02M |
| March 31, 2023 | 34.47M |
| December 31, 2022 | 42.30M |
| September 30, 2022 | 49.62M |
| June 30, 2022 | 56.72M |
| March 31, 2022 | 62.94M |
| December 31, 2021 | 69.45M |
| September 30, 2021 | 76.33M |
| June 30, 2021 | 66.46M |
| March 31, 2021 | 67.97M |
| December 31, 2020 | 44.26M |
| September 30, 2020 | 51.36M |
| June 30, 2020 | 59.26M |
| March 31, 2020 | 68.71M |
| December 31, 2019 | 77.98M |
| Date | Value |
|---|---|
| September 30, 2019 | 86.42M |
| June 30, 2019 | 96.84M |
| March 31, 2019 | 105.81M |
| December 31, 2018 | 114.60M |
| September 30, 2018 | 122.64M |
| June 30, 2018 | 133.22M |
| March 31, 2018 | 143.93M |
| December 31, 2017 | 90.06M |
| September 30, 2017 | 99.70M |
| June 30, 2017 | 110.33M |
| March 31, 2017 | 122.06M |
| December 31, 2016 | 134.90M |
| September 30, 2016 | 145.12M |
| June 30, 2016 | 152.15M |
| March 31, 2016 | 152.30M |
| December 31, 2015 | 94.39M |
| September 30, 2015 | 99.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
27.15M
Minimum
Dec 2023
96.84M
Maximum
Jun 2019
58.29M
Average
59.26M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.378M |
| Arbutus Biopharma Corp | 126.00M |
| Oragenics Inc | 3.484M |
| Relmada Therapeutics Inc | 96.32M |
| MAIA Biotechnology Inc | 7.151M |